BioCentury
ARTICLE | Company News

Alliance receives approvable letter

August 21, 2000 7:00 AM UTC

ALLP received from the FDA an approvable letter for its Imagent (AF0150) ultrasound contrast agent for endocardial border delineation, which was developed with partner Schering (Berlin, Germany). ALLP...